These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 25644677)

  • 1. Treatment of granulomatosis with polyangiitis (Wegener's).
    Pagnoux C; Guillevin L
    Expert Rev Clin Immunol; 2015 Mar; 11(3):339-48. PubMed ID: 25644677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
    Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.
    Miloslavsky EM; Specks U; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Ding L; Iklé D; Villareal M; Lim N; Brunetta P; Fervenza FC; Monach PA; Stone JH;
    Arthritis Rheumatol; 2015 Jun; 67(6):1629-36. PubMed ID: 25776953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
    Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
    J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
    Lally L; Spiera R
    Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab as a new therapeutic option in granulomatosis with polyangiitis: a report of two cases.
    Dalkilic E; Alkis N; Kamali S
    Mod Rheumatol; 2012 Jun; 22(3):463-6. PubMed ID: 21847703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
    Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
    Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab therapy for Wegener's granulomatosis refractory to conventional treatment.
    Sánchez-Escuredo A; Núñez R; Ibernón M; Martínez E; López D; Navarro M; Bonet J; Ara J; Romero R
    Nefrologia; 2011; 31(4):502-4. PubMed ID: 21738261
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
    Azar L; Springer J; Langford CA; Hoffman GS
    Arthritis Rheumatol; 2014 Oct; 66(10):2862-70. PubMed ID: 24943239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective.
    Joshi L; Lightman SL; Salama AD; Shirodkar AL; Pusey CD; Taylor SR
    Ophthalmology; 2011 Dec; 118(12):2498-503. PubMed ID: 21907416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener's granulomatosis).
    Lutalo PM; D'Cruz DP
    J Autoimmun; 2014; 48-49():94-8. PubMed ID: 24485158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity.
    Rasmussen N; Salmela A; Ekstrand A; de Groot K; Gregorini G; Cohen Tervaert JW; Gross WL; Wiik A; Jayne DR;
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S38-44. PubMed ID: 23380137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: update.
    Santana AN; Woronik V; Halpern AS; Barbas CS
    J Bras Pneumol; 2011; 37(6):809-16. PubMed ID: 22241040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulomatosis with polyangiitis (Wegener's).
    Puéchal X
    Joint Bone Spine; 2020 Dec; 87(6):572-578. PubMed ID: 32562697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis.
    Singer O; McCune WJ
    Curr Opin Rheumatol; 2017 May; 29(3):248-253. PubMed ID: 28306595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab induced remission in a patient with Wegener's granulomatosis.
    Kallenbach M; Duan H; Ring T
    Nephron Clin Pract; 2005; 99(3):c92-6. PubMed ID: 15665552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).
    Recillas-Gispert C; Serna-Ojeda JC; Flores-Suárez LF
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2279-84. PubMed ID: 26507398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of gynaecological involvement of granulomatosis with polyangiitis (Wegener's granulomatosis) by rituximab.
    Bastone P; Squifflet JL; Marbaix E; Houssiau F
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-142-4. PubMed ID: 26016766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.